Opus Genetics, Inc. · NASDAQ:IRD
Foundation Fighting Blindness Retinal Degeneration Fund reported a 15.90% stake in Opus Genetics, Inc. (Schedule 13D/A)
Event Apr 30, 2025 · Filed May 6, 2025
Foundation Fighting Blindness Retinal Degeneration Fund reported a 15.90% stake in Opus Genetics, Inc., 9,492,171 shares, with active intent on Apr 30, 2025. Filed May 6, 2025 (Schedule 13D/A).
- Stake
- 15.90%
- Shares
- 9,492,171
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Foundation Fighting Blindness Retinal Degeneration Fund | 15.90% | 9,492,171 |
| Foundation Fight Blindness, Inc. | 15.90% | 9,492,171 |
Source
Related
- Opus Genetics, Inc.
- Foundation Fighting Blindness Retinal Degeneration Fund
- Opus Genetics, Inc. shareholders
- Schedule 13D/A · Foundation Fighting Blindness Retinal Degeneration Fund · May 20, 2026
- Schedule 13D/A · Foundation Fighting Blindness Retinal Degeneration Fund · Dec 11, 2025
- Form 4 · Foundation Fighting Blindness Retinal Degeneration Fund · Oct 2, 2026
- Form 4 · Magrath George · Sep 11, 2026
- Form 4 · Gallagher Cam · Sep 8, 2026
- Form 4 · Gagnon Robert E. · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026